---
figid: PMC6674699__zns0410623580003
figlink: /pmc/articles/PMC6674699/figure/F3/
number: Figure 3
caption: 'Estrogen mechanisms of action that lead to neurotrophic and neuroprotective
  outcomes. Top, 17-β-Estradiol (E2) acting via a membrane-associated site (mER) activates
  a cascade required for multiple responses that lead to enhanced neural plasticity,
  morphogenesis, neurogenesis, and neural survival. The signaling sequence induced
  by E2 at the membrane site is as follows: (1) E2 binding to mER, (2) E2–mER complexes
  with p85 to activate PI3K, (3) activating calcium-independent PKC, (4) phosphorylating
  the L-type calcium channel, (5) inducing calcium influx, (6) activating calcium-dependent
  PKCs, (7) activating Src kinase, (8) activating the MEK/ERK1/2 pathway, (9) ERK
  translocates to the nucleus, (10) activating and phosphorylating CREB, (11) enhancing
  transcription of antiapoptotic genes Bcl-2 and Bcl-xl, which enhance mitochondrial
  vitality, and spinophilin, which encourages synaptic growth, (12) simultaneously,
  estrogen activation of PI3K leads to activation of Akt, which phosphorylates and
  inhibits the proapoptotic protein BAD. Middle, Estrogen-induced neuroprotective
  mechanisms converge on mitochondria. Estrogen-activated cellular signaling cascade
  promotes enhanced mitochondrial function, leading to increased calcium load tolerance,
  enhanced electron transport chain efficiency, and promotion of antioxidant defense
  mechanisms. These actions are mediated by the regulation of both nuclear and mitochondrial
  encoded genes initiated by the activation of second-messenger signaling cascades.
  Bottom, Conceptual schematic of NeuroSERM design and therapeutic use. Consistent
  with the healthy cell bias of estrogen benefit hypothesis, NeuroSERM or PhytoSERM
  molecules would be administered before neurodegenerative insult while neurons are
  still healthy. NeuroSERM exposure would lead to enhanced neural survival mechanisms,
  represented as mitochondria with Bcl-2 additions, that promote neural defense against
  neurodegenerative insults associated with age-associated diseases such as Alzheimer''s
  and Parkinson''s. Designer NeuroSERM molecules target the membrane site of estrogen
  action, whereas PhytoSERM molecules preferentially target estrogen receptor β. AMPAR,
  AMPA receptor; C, cytochrome oxidase; F0, F1, ATPase subunits; LTD, long-term depression;
  LTP, long-term potentiation; NAD, nicotinamide adenine dinucleotide; NADH, nicotinamide
  adenine dinucleotide; VDCC, voltage-dependent calcium channel.'
pmcid: PMC6674699
papertitle: 'Estrogen, Menopause, and the Aging Brain: How Basic Neuroscience Can
  Inform Hormone Therapy in Women.'
reftext: John H. Morrison, et al. J Neurosci. 2006 Oct 11;26(41):10332-10348.
pmc_ranked_result_index: '223592'
pathway_score: 0.5664801
filename: zns0410623580003.jpg
figtitle: Estrogen mechanisms of action that lead to neurotrophic and neuroprotective
  outcomes
year: '2006'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6674699__zns0410623580003.html
  '@type': Dataset
  description: 'Estrogen mechanisms of action that lead to neurotrophic and neuroprotective
    outcomes. Top, 17-β-Estradiol (E2) acting via a membrane-associated site (mER)
    activates a cascade required for multiple responses that lead to enhanced neural
    plasticity, morphogenesis, neurogenesis, and neural survival. The signaling sequence
    induced by E2 at the membrane site is as follows: (1) E2 binding to mER, (2) E2–mER
    complexes with p85 to activate PI3K, (3) activating calcium-independent PKC, (4)
    phosphorylating the L-type calcium channel, (5) inducing calcium influx, (6) activating
    calcium-dependent PKCs, (7) activating Src kinase, (8) activating the MEK/ERK1/2
    pathway, (9) ERK translocates to the nucleus, (10) activating and phosphorylating
    CREB, (11) enhancing transcription of antiapoptotic genes Bcl-2 and Bcl-xl, which
    enhance mitochondrial vitality, and spinophilin, which encourages synaptic growth,
    (12) simultaneously, estrogen activation of PI3K leads to activation of Akt, which
    phosphorylates and inhibits the proapoptotic protein BAD. Middle, Estrogen-induced
    neuroprotective mechanisms converge on mitochondria. Estrogen-activated cellular
    signaling cascade promotes enhanced mitochondrial function, leading to increased
    calcium load tolerance, enhanced electron transport chain efficiency, and promotion
    of antioxidant defense mechanisms. These actions are mediated by the regulation
    of both nuclear and mitochondrial encoded genes initiated by the activation of
    second-messenger signaling cascades. Bottom, Conceptual schematic of NeuroSERM
    design and therapeutic use. Consistent with the healthy cell bias of estrogen
    benefit hypothesis, NeuroSERM or PhytoSERM molecules would be administered before
    neurodegenerative insult while neurons are still healthy. NeuroSERM exposure would
    lead to enhanced neural survival mechanisms, represented as mitochondria with
    Bcl-2 additions, that promote neural defense against neurodegenerative insults
    associated with age-associated diseases such as Alzheimer''s and Parkinson''s.
    Designer NeuroSERM molecules target the membrane site of estrogen action, whereas
    PhytoSERM molecules preferentially target estrogen receptor β. AMPAR, AMPA receptor;
    C, cytochrome oxidase; F0, F1, ATPase subunits; LTD, long-term depression; LTP,
    long-term potentiation; NAD, nicotinamide adenine dinucleotide; NADH, nicotinamide
    adenine dinucleotide; VDCC, voltage-dependent calcium channel.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GRIN3B
  - GRIN1
  - WDTC1
  - AKT3
  - AKT2
  - GRIN3A
  - ATF2
  - AKT1
  - CREB3L4
  - ATF1
  - CREB3L2
  - CREM
  - CREB3L1
  - CREB5
  - BAD
  - CREB3L3
  - MAPK1
  - BRD2
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - GRIN2A
  - GRIN2B
  - GRIN2C
  - GRIN2D
  - MAPK3
  - BCL2L1
  - CREB3
  - CREB1
  - PRKCZ
  - ARAF
  - RAF1
  - PIK3R3
  - PRKD3
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - BCL2
  - PIK3R6
  - PIK3R5
  - PRKCI
  - PRKCQ
  - KRAS
  - NRAS
  - BRAF
  - HRAS
  - PRKCG
  - SRC
  - PRKCH
  - Estrogen
  - Cancer
genes:
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3B
  entrez: '116444'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN1
  entrez: '2902'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3A
  entrez: '116443'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF2
  entrez: '1386'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L4
  entrez: '148327'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L2
  entrez: '64764'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREM
  entrez: '1390'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L1
  entrez: '90993'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB5
  entrez: '9586'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3L3
  entrez: '84699'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Nat.
  symbol: NAT
  source: hgnc_alias_symbol
  hgnc_symbol: BRD2
  entrez: '6046'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2A
  entrez: '2903'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2B
  entrez: '2904'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2C
  entrez: '2905'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2D
  entrez: '2906'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Bcl-2/Bcl-xL
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB3
  entrez: '10488'
- word: CREB
  symbol: CREB
  source: bioentities_symbol
  hgnc_symbol: CREB1
  entrez: '1385'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
chemicals:
- word: Estrogen
  source: MESH
  identifier: D004967
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
